Penn Medicine halts gender-affirming surgery for patients under 19 following Trump executive order
“This is a difficult decision that we know impacts patients and families who place their trust in our care teams,” Patrick Brennan, Penn Medicines’s chief medical officer, wrote in a statement.


















